Oncology PracticeOsimertinib improves survival in advanced NSCLCSeptember 29, 2019Lung CancerLung Cancer
Oncology PracticeBAROCCO study: Cediranib-olaparib combination shows promise in PROCSeptember 28, 2019Gynecologic Cancer
Oncology PracticeAdjuvant radiotherapy no better than salvage post prostatectomySeptember 28, 2019Genitourinary Cancer
Hematology NewsSecond-generation anti-BCMA CAR T-cell therapy shows promise in myeloma trialSeptember 27, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticePatient-reported outcomes are here to staySeptember 27, 2019Practice ManagementBusiness of MedicinePatient & Survivor Care
Oncology PracticeCMS weighs extension of Oncology Care ModelSeptember 27, 2019Practice ManagementBusiness of Medicine
Hematology NewsGerman CLLM1 study: 4-year data raise concerns about lenalidomide maintenanceSeptember 27, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeCheckMate 817: Nivo+ipi shows safety, efficacy across stage IV NSCLC subgroupsSeptember 27, 2019Lung Cancer
Hematology NewsICLL-07 trial: MRD-driven strategy yields prolonged survivalSeptember 27, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeCancer drug prices higher in U.S. than Europe; don’t correlate with clinical benefitSeptember 27, 2019Business of MedicinePractice Management
Hematology NewsSubcutaneous and IV daratumumab combos appear comparable in myelomaSeptember 26, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsQuadruplet prolongs progression-free survival in newly diagnosed myelomaSeptember 26, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsGALACTIC CLL trial: Obinutuzumab consolidation helps eradicate MRDSeptember 26, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeOS benefit with pembrolizumab endures long-term in advanced NSCLCSeptember 24, 2019Lung CancerImmuno-oncology
Oncology PracticeHormone therapy may do more harm than good for men with low PSA before early salvage radiationSeptember 24, 2019Genitourinary Cancer